Stereotaxis, Inc.
Stereotaxis, Inc. (STXS) Financial Performance & Income Statement Overview
Analyze Stereotaxis, Inc. (STXS) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Stereotaxis, Inc. (STXS) Income Statement & Financial Overview
View the income breakdown for Stereotaxis, Inc. STXS across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $7.47M | $6.34M | $9.20M | $4.50M |
| Cost of Revenue | $3.41M | $3.12M | $5.10M | $1.19M |
| Gross Profit | $4.06M | $3.22M | $4.10M | $3.31M |
| Gross Profit Ratio | $0.54 | $0.51 | $0.45 | $0.74 |
| R&D Expenses | $2.35M | $2.79M | $2.45M | $2.27M |
| SG&A Expenses | $7.64M | $8.05M | $7.99M | $7.06M |
| Operating Expenses | $9.99M | $10.84M | $10.44M | $9.33M |
| Total Costs & Expenses | $13.40M | $13.97M | $15.54M | $10.52M |
| Interest Income | $0.00 | $114000.00 | $150000.00 | $191000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $363000.00 | $330000.00 | $136000.00 |
| EBITDA | -$5.93M | -$7.15M | -$6.01M | -$5.88M |
| EBITDA Ratio | -$0.79 | -$1.13 | -$0.65 | -$1.31 |
| Operating Income | -$5.93M | -$7.63M | -$6.34M | -$6.02M |
| Operating Income Ratio | -$0.79 | -$1.20 | -$0.69 | -$1.34 |
| Other Income/Expenses (Net) | -$208000.00 | $112000.00 | $155000.00 | $188000.00 |
| Income Before Tax | -$6.14M | -$7.51M | -$6.19M | -$5.83M |
| Income Before Tax Ratio | -$0.82 | -$1.19 | -$0.67 | -$1.30 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$6.14M | -$7.51M | -$6.19M | -$5.83M |
| Net Income Ratio | -$0.82 | -$1.19 | -$0.67 | -$1.30 |
| EPS | -$0.07 | -$0.08 | -$0.08 | -$0.07 |
| Diluted EPS | -$0.07 | -$0.08 | -$0.08 | -$0.07 |
| Weighted Avg Shares Outstanding | $87.77M | $86.83M | $85.82M | $84.57M |
| Weighted Avg Shares Outstanding (Diluted) | $87.77M | $86.83M | $85.82M | $84.57M |
Over the past four quarters, Stereotaxis, Inc. demonstrated steady revenue growth, increasing from $4.50M in Q2 2024 to $7.47M in Q1 2025. Operating income reached -$5.93M in Q1 2025, maintaining a consistent -79% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$5.93M, reflecting operational efficiency. Net income rose to -$6.14M, with EPS at -$0.07. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan